From the publishers of JADPRO

Renal Cell Carcinoma Resource Center

Advertisement

How we treat metastatic renal cell carcinoma: Options beyond first-line therapy

Last Updated: Thursday, December 21, 2023

This review uses data from retrospective cohorts and prospective studies investigating post-frontline therapy options for patients with mRCC and shares practical considerations to aid oncology practitioners in optimizing therapy selection in the second-line setting.

ASCO Daily News
Advertisement
News & Literature Highlights
Advertisement
Advertisement